Severe Liver Injury Associated with Glecaprevir Plus Pibrentasvir Therapy in a Patient with Treatment-naïve Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

Severe Liver Injury Associated with Glecaprevir Plus Pibrentasvir Therapy in a Patient with Treatment-naïve Hepatitis C Virus Infection

Published:2021-08-01 Issue:15 Volume:60 Page:2437-2443
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hara Tasuku¹,Ohara Tomoya¹,Taniguchi Masashi¹,Sakai Hiroaki¹,Oka Kohei¹,Iwai Naoto¹,Tsuji Toshifumi¹,Okuda Takashi¹,Nagata Akihiro²,Komaki Toshiyuki¹,Sakagami Junichi¹,Kagawa Keizo¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan

2. Department of Pathology, Fukuchiyama City Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/15/60_6664-20/_pdf

Reference26 articles.

1. 1. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Disease. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49: 1335-1374, 2009.

2. 2. Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med 166: 637-648, 2017.

3. 3. Zeuzem S, Foster GR, Wang S, et al. Glecaprevir-Pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection. N Engl J Med 378: 354-369, 2018.

4. 4. Forns X, Lee SS, Valdes J, et al. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre Phase 3 trial. Lancet Infect Dis 17: 1062-1068, 2017.

5. 5. Toyoda H, Chayama K, Suzuki F, et al. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection. Hepatology 67: 505-513, 2018.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety considerations in the management of hepatitis C and HIV co-infection;Expert Opinion on Drug Safety;2023-04-27

2. Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid;Viruses;2023-02-09

3. Acute Liver Injury due to Glecaprevir/Pibrentasvir in a Patient with Chronic Hepatitis C Virus Infection without Cirrhosis;Avicenna Journal of Medicine;2022-07

4. Multiple drugs;Reactions Weekly;2021-09